Research Insights

Pulsed Field Ablation Market Overview Pulsed field ablation market, a growing segment of the cardiac ablation market, is anticipated to grow at a compounded annual growth rate (CAGR) of ~40% during the forecast period 2023-2035. Over the years, medical researchers and practitioners have actively pursued the development of minimally invasive procedures that are less painful, have shorter recovery periods, and offer improved patient outcomes. Such techniques have been able to carve out a niche

...read more

Antibody Discovery Services and Platforms Market Overview The global antibody discovery services and platforms market size is estimated to be worth over $1.6 billion in 2023 and is expected to grow at a compounded annual growth rate (CAGR) of 12.0% during the forecast period. The usual drug development process, beginning from discovery to commercialization of a clinically validated product spans around 10-15 years and requires investments of over $2 billion. However, despite the extensiv

...read more

Agricultural Biologicals Market Overview The global agricultural biologicals market (including biopesticides market, biofertilizers market and biostimulants market) is estimated to be worth $13.76 billion in 2023. The global market is anticipated to grow at a CAGR of 9.98% during the forecast period. The growth in the market size over the next decade is likely to be the result of a rise in the demand for organic food coupled with the growing focus on sustainable agriculture. Agricultu

...read more

Next Generation Drug Conjugates Market Overview The global market for the next generation drug conjugates is expected to grow at a compounded annual growth rate (CAGR) of more than 20% during the forecast period. The next generation drug conjugates, owing to their non-immunogenic nature, better clinical profile, structural stability, limited side effects, targeted delivery of payload, deeper cellular penetration, and permeability, have emerged as the viable targeted therapeutics for rare

...read more

Plasma Fractionation Market Overview The global plasma fractionation market is estimated to be worth $ 4.4 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of ~10% during the forecast period. Over the past two decades, the number of patients affected with rare diseases have increased tremendously. In fact, over 410 million people are currently suffering from rare and chronic disorders. Given the growing prevalence of the aforementioned disorders, the demand

...read more

RNA Therapeutics and RNA Vaccines Market Overview The global RNA Vaccines and RNA Therapeutics market is estimated to be worth over USD 1.1 billion in 2035 and is expected to grow at compounded annual growth rate (CAGR) of 50% during the forecast period (2026-2035). In the past few years, RNA based therapeutics have emerged as one of the key therapeutic modalities in the modern healthcare industry. These RNA based therapeutics play a crucial role in protein production and regulation of gene f

...read more

Wearable Injectors Market Overview The global wearable injectors market is estimated to be worth $4.3 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 9% during the forecast period. With the increasing population, the incidence rates of various chronic diseases, such as diabetes, autoimmune diseases, cardiovascular diseases, and oncological diseases, are witnessing an upward trend. The pharmaceutical stakeholders have made numerous efforts by incorporating in

...read more

Cryopreservation bags and Freezing Bags Market Overview The global market for cryopreservation bags and freezing bags is expected to grow at compounded annual growth rate (CAGR) of 8% during the forecast period. Cryopreservation is a technique that aids in maintaining biological materials at cryogenic temperatures for an extended period of time, while preserving the original cell structures. Owing to its ability to store a wide variety of elements, including cells, tissues, blood and DNA, cry

...read more

Chromatography Consumables and Chromatography Instrumentation Market Overview The global chromatography market size, including chromatography instrumentation market (liquid chromatography system market, gas chromatography market, gel permeation chromatography market and others) and chromatography consumables market, is estimated to be worth USD 10.5 billion in 2023. The global chromatography market is anticipated to grow at a CAGR of 5.5% during the forecast period. Chromatography is an an

...read more

Pre-Sterilized / Ready to Use Pharmaceutical Packaging Market Overview The global pre-sterilized / ready to use pharmaceutical packaging market is estimated to be worth USD 9.01 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 6.62%, during the forecast period. In the pharmaceutical industry, the integrity and safety of drugs and vaccines are of utmost importance. The primary packaging of such products plays an important role in ensuring their quality and pro

...read more

Plamid DNA Manufacturing Market Overview The global plasmid DNA manufacturing market is anticipated to grow at compounded annual growth rate (CAGR) of ~15% during the forecast period. The plasmid DNA manufacturing market is a dynamic and rapidly growing sector that plays a pivotal role in biotechnology and genetic research. Plasmid DNA is a circular, double-stranded DNA molecule that replicates independently of chromosomal DNA. With its ability to be genetically engineered, plasmid DNA s

...read more

Single Use Bioreactors Market Overview The global single use bioreactors market is estimated to be worth USD 1.3 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of ~17% during the forecast period. Over the past few years, biopharmaceuticals have gained significant attention owing to their therapeutic efficacy. In fact, in the past two decades, over 170 biologics have received the USFDA approval, while over 10,000 biologics are currently under different stages o

...read more

Allogeneic Cell Therapy Market Overview The global allogeneic cell therapy market is estimated to be worth USD 0.54 Million in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 14.5% during the forecast period 2023-2035. Allogeneic cell therapies refer to off-the-shelf therapies that are isolated from donor tissues (such as cord blood and bone marrow), processed ex vivo in the labs and then administered into patients / cryopreserved in a cell bank. Since these therapies

...read more

Medical Drones Market Overview The global medical drones market is expected to grow at compounded annual growth rate (CAGR) of around 15% during the forecast period. Drones are becoming indispensable in the healthcare industry, serving various functions, such as delivering drugs, medical kits, vaccines, organs and surgical equipment. The timely delivery of critical medical resources has gradually prompted a wider adoption of medical delivery drones, mitigating logistical challenges and enhanc

...read more

Automated Liquid Handling Systems Market Overview The global market size of automated liquid handling systems is estimated to be around USD 2.82 billion in 2023 and expected to grow at compounded annual growth rate (CAGR) of more than 7.4%, during the forecast period, 2023-2035. It is a well-known fact that innovation in the life science industry is primarily driven by advanced technologies that possess the tendency to maximize assay throughput and frequency. Owing to the growing demand for c

...read more

AI In Clinical Trials Overview The global AI in clinical trials market is estimated to be worth $ 1.4 billion in 2023 and expected to grow at compounded annual growth rate (CAGR) of 16% during the forecast period. The process of successfully developing a novel therapeutic intervention is both time and cost intensive. In fact, it is estimated that a drug requires around 10 years and over $ 2.5 billion capital investment, before reaching the market. In this process, clinical trials play a cruci

...read more

Patient Engagement Market Overview The global patient engagement solutions market is estimated to be worth over USD 11.4 billion in 2023 and expected to grow at compounded annual growth rate (CAGR) of 19.4% during the forecast period.  Patient engagement solutions play a vital role in empowering patients to actively participate in their healthcare journey, fostering better patient outcomes and experiences. These patient engagement software and digital patient engagement platform enabl

...read more

Antibody Drug Conjugate Market Overview The global antibody drug conjugate market is estimated to be worth USD 7.72 billion in 2023 and expected to grow at compounded annual growth rate (CAGR) of 9.63% during the forecast period. Antibody drug conjugates are engineered therapeutics comprised of monoclonal antibodies attached to potent cytotoxic payloads through chemical linkers. Over the years, various technological advancements, such as antibody engineering for site-specific conjugation and

...read more

ADC Technology Overview: ADC Linker and Antibody Conjugation The ADC technology market, comprising of ADC linker and antibody conjugation technologies is expected to grow at compounded annual growth rate (CAGR) of ~15% during the forecast period. Antibody drug conjugates have emerged as a promising alternative to the conventional anti-cancer therapies. Till date, around 14 ADCs have received the USFDA approval, while over 420 antibody drug conjugates are currently being evaluated under d

...read more

Organ On Chip Overview The global organ-on-a-chip market is anticipated to grow at a compounded annual growth rate (CAGR) of 21% during the forecast period, mainly driven by the rise in research activity within the pharmaceutical industry. It is a well-known fact that almost 90% of the therapeutic interventions fail in clinical trials, resulting in significant economic losses to the pharmaceutical industry. The lack of effective preclinical prediction of drug responses in humans is one o

...read more
  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry